United Asset Strategies’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-143,198
| Closed | -$6.48M | – | 177 |
|
|
2019
Q4 | $6.48M | Buy |
143,198
+2,571
| +2% | +$116K | 1.26% | 25 |
|
|
2019
Q3 | $5.72M | Buy |
140,627
+33,532
| +31% | +$1.36M | 1.25% | 28 |
|
|
2019
Q2 | $4.6M | Buy |
107,095
+3,405
| +3% | +$146K | 1.06% | 33 |
|
|
2019
Q1 | $3.98M | Buy |
103,690
+5,190
| +5% | +$199K | 0.94% | 36 |
|
|
2018
Q4 | $3.48M | Buy |
98,500
+5,994
| +6% | +$212K | 0.95% | 34 |
|
|
2018
Q3 | $3.56M | Sell |
92,506
-1,107
| -1% | -$42.6K | 0.84% | 44 |
|
|
2018
Q2 | $3.06M | Buy |
93,613
+1,313
| +1% | +$42.9K | 0.81% | 43 |
|
|
2018
Q1 | $2.52M | Buy |
92,300
+13,785
| +18% | +$377K | 0.74% | 45 |
|
|
2017
Q4 | $1.95M | Buy |
78,515
+400
| +0.5% | +$9.91K | 0.52% | 55 |
|
|
2017
Q3 | $2.28M | Sell |
78,115
-98,245
| -56% | -$2.87M | 1.29% | 26 |
|
|
2017
Q2 | $4.89M | Sell |
176,360
-30,605
| -15% | -$848K | 1.45% | 24 |
|
|
2017
Q1 | $5.15M | Buy |
206,965
+37,380
| +22% | +$930K | 1.57% | 23 |
|
|
2016
Q4 | $3.67M | Buy |
169,585
+70,125
| +71% | +$1.52M | 1.2% | 35 |
|
|
2016
Q3 | $2.37M | Sell |
99,460
-1,825
| -2% | -$43.4K | 0.83% | 42 |
|
|
2016
Q2 | $2.37M | Sell |
101,285
-660
| -0.6% | -$15.4K | 0.89% | 40 |
|
|
2016
Q1 | $1.92M | Buy |
+101,945
| New | +$1.92M | 0.86% | 39 |
|